Hepatitis B

The Virus, the Disease, and the Vaccine

  • Irving Millman
  • Toby K. Eisenstein
  • Baruch S. Blumberg

Table of contents

  1. Front Matter
    Pages i-xi
  2. Introduction

    1. Toby K. Eisenstein
      Pages 1-3
  3. Keynote Address: The Australia Antigen Story

    1. Baruch S. Blumberg
      Pages 5-31
  4. The Virus and its Transmission

    1. Jesse Summers
      Pages 33-43
    2. W. Thomas London
      Pages 45-53
    3. Jules L. Dienstag
      Pages 55-65
  5. Clinical and Diagnostic Perspectives of HBV

    1. Evgenya Skarinsky, Emanuel Rubin
      Pages 67-93
    2. Chung-Mei Ling
      Pages 95-104
    3. Barbara G. Werner, Jules L. Dienstag, Barbara J. Kuter, David R. Snydman, B. Frank Polk, Donald E. Craven et al.
      Pages 105-111
    4. Vernon J. Brightman, Robert Weibel
      Pages 123-135
  6. The Vaccine

    1. Irving Millman
      Pages 137-147
    2. Arlene A. McLean, Eugene B. Buynak, Barbara J. Kuter, Maurice R. Hilleman, David J. West
      Pages 149-159
    3. Robert E. Weibel
      Pages 161-174
    4. Roger H. Bernier, Mark A. Kane, Neal Nathanson, Donald P. Francis
      Pages 175-187
  7. Vaccine Economics: Issues and Answers

    1. Robert J. Gerety
      Pages 189-194
  8. Vaccines of the Future

    1. G. R. Dreesman, I. Ionescu-Matiu, Y. Sanchez, R. C. Kennedy, J. T. Sparrow, J. L. Melnick
      Pages 215-224
    2. Pablo Valenzuela, Paulina Bull, Doris Coit, Brian Craine, Robert Hallewell, Ulrike Heberlein et al.
      Pages 225-236
    3. Irving Millman
      Pages 237-240
  9. Back Matter
    Pages 241-251

About this book


Toby K. Eisenstein Symposium Committee Chairperson Temple University School of Medicine Philadelphia, Pennsylvania 19140 This symposium is the thirteenth biennial clinical microbiology program sponsored by the Eastern Pennsylvania Branch of the American Society for Microbiology in cooperation with the Philadelphia area medical schools and the Bureau of Laboratories of the Pennsylvania Department of Health. This year a generous contribution from Merck, Sharp and Dohme has helped to make the program a reality. The subject matter for this symposium represents an attractive spectrum of medical, biological and molecular approaches to the practical solution of a public health prob1em--name1y, prevention of infection with the hepatitis B virus. The symposium may be unique in that it focuses on a product which was first marketed less than three months ago, but included in the program are presen­ tations on two new approaches to hepatitis B vaccine production which may replace the one which is newly unveiled. The rapidity of progress in our present era of biological research is indeed astonishing.


Antigen cell hepatitis hepatitis B hepatitis b virus infection liver microbiology research society vaccine virus

Editors and affiliations

  • Irving Millman
    • 1
  • Toby K. Eisenstein
    • 2
  • Baruch S. Blumberg
    • 1
  1. 1.Institute for Cancer ResearchFox Chase Cancer CenterPhiladelphiaUSA
  2. 2.Temple University School of MedicinePhiladelphiaUSA

Bibliographic information